{
    "code": "02025360",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025360",
    "time": "2018-12-21 03:42:00",
    "許可證字號": "衛署藥輸字第025360號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/10\/18",
    "發證日期": "101\/10\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202536008",
    "中文品名": "傲迪適眼後段植入劑",
    "英文品名": "Ozurdex (dexamethasone intravitreal implant) 0.7mg",
    "適應症": "因 BRVO (Branch Retinal Vein Occlusion)  或 CRVO (Central Retinal Vein Occlusion)  導致黃斑部水腫。用於影響眼後段的非感染性葡萄膜炎的治療。 糖尿病黃斑部水腫 (DME)所導致的視力損害。",
    "劑型": "200植入劑",
    "包裝": "0.7mg填充於單次使用之塑膠注射器",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "DEXAMETHASONE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "620118K767  台灣愛力根藥品股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F230008000  ALLERGAN PHARMACEUTICALS IRELAND",
        "製造廠廠址": "CASTLEBAR ROAD, WESTPORT,  COUNTY MAYO, IRELAND",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F230071000  SYNERGY HEALTH WESTPORT LIMITED",
            "製造廠廠址": "CARROWBEG INDUSTRIAL ESTATE, LODGE ROAD, WESTPORT, CO. MAYO, IRELAND",
            "製造廠公司地址": "",
            "製造廠國別": "IRELAND",
            "製程": ""
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6804000600",
            "成分名稱": "DEXAMETHASONE",
            "含量描述": "",
            "含量": "0.7000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "010253600001-107-06-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025360&Seq=006&Type=9"
        },
        {
            "title": "Chinese sticker_08Nov___20121221.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025360&Seq=006&Type=8"
        }
    ]
}